Enanta Pharmaceuticals Stock Options Expiring on 17th of January 2025
| ENTA Stock | USD 8.60 0.23 2.60% |
Enanta Pharmaceuticals' latest option contracts expiring on 2025-01-17 are carrying combined implied volatility of 0.82 with a put-to-call open interest ratio of 0.39 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2025-01-17. The total put volume is at 19.0, with calls trading at the volume of 19.0. This yields a 0.79 put-to-call volume ratio.
Open Interest Against 2025-01-17 Option Contracts
2025-01-17
The chart above shows Enanta Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Enanta Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Enanta Pharmaceuticals' option, there is no secondary market available for investors to trade.
Enanta Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Enanta Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Enanta stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Enanta Pharmaceuticals' stock price goes up or down, the stock options follow.
The current year's Stock Based Compensation To Revenue is expected to grow to 0.42, whereas Common Stock Shares Outstanding is forecasted to decline to about 18.4 M. Enanta Current Options Market Mood
Enanta Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Enanta Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Enanta Pharmaceuticals' options investors are not very successful. Enanta Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Enanta contract
Base on the Rule 16, the options market is currently suggesting that Enanta Pharmaceuticals will have an average daily up or down price movement of about 0.0513% per day over the life of the 2025-01-17 option contract. With Enanta Pharmaceuticals trading at USD 8.6, that is roughly USD 0.004408. If you think that the market is fully incorporating Enanta Pharmaceuticals' daily price movement you should consider buying Enanta Pharmaceuticals options at the current volatility level of 0.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Enanta |
Enanta Pharmaceuticals Option Chain
When Enanta Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Enanta Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Enanta Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Enanta. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Enanta. It also shows strike prices and maturity days for a Enanta Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | ENTA Option Call 17-01-2025 10 | 37 | 2025-01-17 | 0.0 - 0.0 | 0.7 | Out |
Call | ENTA Option Call 17-01-2025 12 | 26 | 2025-01-17 | 0.0 - 0.0 | 1.66 | Out |
Call | ENTA Option Call 17-01-2025 15 | 20 | 2025-01-17 | 0.0 - 0.0 | 0.5 | Out |
Call | ENTA Option Call 17-01-2025 17 | 0 | 2025-01-17 | 0.0 - 0.85 | 1.23 | |
Call | ENTA Option Call 17-01-2025 20 | 14 | 2025-01-17 | 0.0 - 2.0 | 1.3 | Out |
Put | ENTA Option Put 17-01-2025 10 | 20 | 2025-01-17 | 0.6 - 1.9 | 0.75 | In |
Put | ENTA Option Put 17-01-2025 12 | 12 | 2025-01-17 | 1.35 - 4.0 | 2.3 | In |
Put | ENTA Option Put 17-01-2025 15 | 6 | 2025-01-17 | 2.85 - 5.4 | 2.1 | In |
Enanta Total Stockholder Equity
Total Stockholder Equity |
|
Enanta Pharmaceuticals Corporate Management
| Nathaniel JD | General VP | Profile | |
| Scott MD | Senior Officer | Profile | |
| Nathalie MD | Consultant | Profile | |
| Jennifer Viera | Senior Communications | Profile | |
| Tara Kieffer | Senior Development | Profile | |
| Brendan Luu | Senior Development | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enanta Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (5.48) | Revenue Per Share 3.407 | Quarterly Revenue Growth (0.05) | Return On Assets (0.17) |
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.